US 12391750
Anti-C1S antibodies and methods of use thereof
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 12391750 (Anti-C1S antibodies and methods of use thereof) held by Bioverativ USA Inc. expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Bioverativ USA Inc.
- Grant date
- Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61K45/06, A61P